2017
DOI: 10.1101/gr.220533.117
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity

Abstract: The tumor suppressor TP53 is the most frequently mutated gene product in human cancer. Close to half of all solid tumors carry inactivating mutations in the TP53 gene, while in the remaining cases, TP53 activity is abrogated by other oncogenic events, such as hyperactivation of its endogenous repressors MDM2 or MDM4. Despite identification of hundreds of genes regulated by this transcription factor, it remains unclear which direct target genes and downstream pathways are essential for the tumor suppressive fun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

20
189
4

Year Published

2019
2019
2024
2024

Publication Types

Select...
3
2
2

Relationship

1
6

Authors

Journals

citations
Cited by 139 publications
(220 citation statements)
references
References 42 publications
20
189
4
Order By: Relevance
“…Despite this activity, the large majority of p53 genomic binding events occur within regions that are accessible before p53 engagement (10,48,54,59), similar to what is observed for glucocorticoid receptor binding (66). These regions also contain chromatin modifications associated with active CRE, including H3K27ac and H3K4me1/2 before p53 binding (1,48,54,59,60,60). Further, p53 depletion does not alter basal CRE-associated chromatin modifications or chromatin structure at the large majority of CRE (48,54).…”
Section: The Requirement For Other Transcription Factors Co-regulatinmentioning
confidence: 67%
See 3 more Smart Citations
“…Despite this activity, the large majority of p53 genomic binding events occur within regions that are accessible before p53 engagement (10,48,54,59), similar to what is observed for glucocorticoid receptor binding (66). These regions also contain chromatin modifications associated with active CRE, including H3K27ac and H3K4me1/2 before p53 binding (1,48,54,59,60,60). Further, p53 depletion does not alter basal CRE-associated chromatin modifications or chromatin structure at the large majority of CRE (48,54).…”
Section: The Requirement For Other Transcription Factors Co-regulatinmentioning
confidence: 67%
“…We then examined the activity of our putative CREs using the model human colon carcinoma cell line HCT116 which is well-suited for studying p53-dependent transcriptional activity. Our 296 potential p53dependent CREs clustered into two groups based on p53 occupancy using ChIP-seq data from HCT116 cells (1). 169 out of 296 regions were scored as p53 binding sites (peaks) by MACS (Bound, Figure 1B), whereas 127 regions lacked measurable p53 binding (Unbound, Figure 1C).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Since transcriptional changes caused by Nutlin treatment are invariably multifunctional (Andrysik et al, 2017), we first asked if differences in cell outcome could be explained by translatome differences. To investigate this possibility, we chose two cell lines which are known to respond differently to treatment with Nutlin as a model system.…”
Section: The Translatomes Of Cells Undergoing Apoptosis or Cell-cyclementioning
confidence: 99%